Modelling HIV prevention: strengths and limitations of different modelling approaches

Size: px
Start display at page:

Download "Modelling HIV prevention: strengths and limitations of different modelling approaches"

Transcription

1 Modelling HIV prevention: strengths and limitations of different modelling approaches Leigh Johnson Centre for Infectious Disease Epidemiology and Research

2 Background Models of HIV differ greatly in their level of complexity, structure and assumptions. There is no right model for all research questions. Rather, the appropriateness of a model depends on the research question it aims to address. This presentation aims to describe the different types of model and their strengths and limitations.

3 From population averages to cohort-based, to individual-based The simplest models are based on population averages : all HIV-negative individuals are assumed to have the same rate of HIV acquisition. Cohort-based models: the population is divided into cohorts of individuals with similar characteristics, and within each cohort all individuals are assumed to have the same rate of HIV acquisition. Individual-based/microsimulation models: characteristics are determined separately for each individual in the population (a.k.a. agent-based modelling). Cohort-based models and models based on population averages are often described as compartmental.

4 Heterogeneity in HIV acquisition risk Individual-based models are best placed to represent heterogeneity in HIV acquisition risk, though cohort-based approaches may also be acceptable. This is important because the simulated impact of HIV prevention programmes is sensitive to the assumed level of heterogeneity in HIV acquisition risk: higher assumed heterogeneity is associated with smaller intervention impact. e.g. We simulated the historic impact of changes in condom use and ART rollout in South Africa, and assessed the correlation between the combined intervention impact and the modelled heterogeneity in HIV acquisition risk.

5 The association between heterogeneity in susceptibility and intervention impact 3.6 Coefficient of variation in incidence % 35% 40% 45% 50% 55% 60% % reduction in incidence due to intervention More heterogeneity Source: Johnson et al (2012)

6 Metapopulation models Metapopulation models are often used to represent geographical heterogeneity. The population is divided into a number of geographic subpopulations (e.g. different cities or districts). Individuals are assumed to have contact mostly with other individuals in the same sub-population, though some individuals have contacts outside of their own sub-population, which creates opportunity for disease spread. Also known as patch models. Source: Mishra et al (2011)

7 Metapopulation model structure Source: Chen et al (2009)

8 Advantages of metapopulation models Important for understanding why HIV incidence and prevalence differs between regions. Useful for characterizing low-prevalence sub-populations according to whether their infections are mostly imported or are mostly locally acquired. Important for modelling geographically-targeted HIV prevention programmes.

9 Stochastic vs deterministic models Stochastic models allow events (e.g. acquisition of infection, death) to be simulated by random processes. Deterministic models work with expected numbers of events in cohorts of individuals. Individual-based models are usually stochastic, while compartmental models are usually deterministic. Stochastic models generate different results every time they are run, because different random values are generated each time the model is run. Deterministic models generate the same result every time they are run (provided input parameters remain the same).

10 Advantages and disadvantages Advantages of stochastic models Important in understanding the role of random variation in determining the uncertainty around epidemic outcomes. Individual-based models (which are usually stochastic) are generally considered more realistic than deterministic models. Important in modelling probabilities of disease extinction. Disadvantages of stochastic models Slower to run. Models usually need to be run several times to generate a distribution of possible outcomes (long run times). Model results are less predictable than in deterministic models and hence stochastic models are more difficult to check and validate.

11 Frequency-dependent models versus pair models Frequency-dependent models assume that the rate of HIV acquisition is proportional to the frequency of HIV in specified model compartments (also known as mean-field or mixing models). Pair models classify individuals according to both their own HIV status and their partner s HIV status, so that the rate of HIV acquisition depends only on whether their current partner is infected. Network models are pair models that allow for concurrent partnerships.

12 Differences in times to transmission Pair model Frequency-dependent model 1. Person A transmits STI to person B 1. Person B acquires STI from risk pool A B 2. Relationship between A and B ends B A B 3. B forms new relationship with C 2. B is at risk of transmitting infection to any susceptible person in risk pool B C 4. B transmits infection to C B B C Source: Johnson & Geffen (2016)

13 Advantages of pair/network models Important when simulating interventions that target partners of index cases, e.g. PrEP for individuals in sero-discordant relationships, assisted partner notification. Better for understanding the role of behavioural factors such as concurrency. Generally considered more realistic. Johnson & Geffen (2016) compared a network model and a frequencydependent model that were identical in structure and found that the simulated impact of interventions targeted to high-risk groups was much greater in the network model than in the frequency-dependent model.

14 Dynamic vs static models In dynamic models of infectious disease transmission, the incidence of infection depends on the prevalence of infection and therefore can change over time as the prevalence in the population changes. In static models, the incidence of infection is assumed to be independent of prevalence, or is constant. This independence assumption is usually only justified when considering very short-term projections, or when modelling infectious diseases that do not change in prevalence over time. Static models are often used in cost-effectiveness analyses. Source: Mishra et al (2011)

15 The basic reproductive number (R 0 ) This is defined as the average number of secondary cases of infection generated by one primary case in a susceptible population. This is a measure of the infectiousness of a disease: If R 0 >1, the disease will spread and there will be an epidemic. If R 0 <1, the disease will die out. Hence much disease modelling work has focused on how effective/widely implemented prevention strategies need to be in order to reduce R 0 below 1. Source: Anderson & May (1992)

16 Steady-state prevalence Non-linearities in dynamic models Example: Suppose we have a chronic infectious disease with R 0 = 4. We simulate the effect of vaccination at different coverage levels (r) on the long-term ( steady-state ) prevalence of the disease. 80% 70% 60% 50% 40% 30% 20% 10% 0% At r 0.75, we have herd immunity (everyone protected). At r < 0.75, there is a non-linear relationship between r and the prevalence of disease. 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50% 55% 60% 65% 70% 75% 80% 85% 90% 95% 100% Vaccination proportion

17 Disadvantages of static models They cannot represent the non-linearities referred to previously. For this reason, they are only appropriate when evaluating a) Very short-term impacts, b) Impacts of interventions that are expected to be small at a population level (i.e. minimal feedback), or c) Non-communicable diseases Not capable of explaining observed time trends in HIV prevalence or AIDS mortality.

18 Mechanistic vs phenomenological models Mechanistic models relate HIV incidence to specific assumed behaviours and interventions. Phenomenological models simulate HIV incidence based on mathematical functions, where the function parameters are not related to real-world variables. e.g. The Epidemic Projection Package (EPP), used by UNAIDS to estimate trends in HIV incidence, uses cubic splines to represent changes in HIV transmission risk over time. Disadvantages of phenomenological approach: Not appropriate to modelling the impact of HIV prevention. Not able to explain why HIV incidence rates are changing.

19 References Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press; 1992 Chen MI, Ghani AC, Edmunds WJ. A metapopulation modelling framework for gonorrhoea and other sexually transmitted infections in heterosexual populations. Journal of the Royal Society Interface 2009, 6: El-Sayed AM, Scarborough P, Seemann L, Galea S. Social network analysis and agent-based modeling in social epidemiology. Epidemiologic Perspectives and Innovations 2012; 9:1. Johnson LF, Geffen N. A comparison of two mathematical modeling frameworks for evaluating sexually transmitted infection epidemiology. Sexually Transmitted Diseases 2016; 43(3): Johnson LF, Hallett TB, Rehle TM, Dorrington RE. The effect of changes in condom usage and antiretroviral treatment coverage on HIV incidence in South Africa: a model-based analysis. Journal of the Royal Society Interface 2012; 9(72): Mishra S, Fisman DN, Boily MC. The ABC of terms used in mathematical models of infectious diseases. Journal of Epidemiology and Community Health 2011, 65:87-94.

DAY 1: MODELING ACTS versus PARTNERSHIPS

DAY 1: MODELING ACTS versus PARTNERSHIPS DAY 1: MODELING ACTS versus PARTNERSHIPS NME WORKSHOP Darcy Rao Objectives Objectives Delve deeper into how compartmental and agentbased models represent partnership dynamics How are sex partners selected?

More information

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS KEY POPULATIONS PREVENTION INTERVENTIONS Ms E Marumo HIV PREVENTION STRATEGIES 13 June 2017 1 Background SA has about 7.1 million people living with HIV

More information

Multiple choice questions: ANSWERS

Multiple choice questions: ANSWERS Multiple choice questions: ANSWERS Chapter 1. Diagnosis and promotion of serostatus awareness in sub-saharan Africa 1. Antiretroviral therapy reduces HIV transmission from a HIV- positive person to a susceptible

More information

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018 South Africa s National HIV Programme Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH 23 October 2018 Overview The HIV and AIDS sub-programme at NDOH is responsible for: policy formulation, coordination,

More information

Elimination of HIV in South Africa through Expanded Access to Antiretroviral Therapy: A Model Comparison Study

Elimination of HIV in South Africa through Expanded Access to Antiretroviral Therapy: A Model Comparison Study Elimination of HIV in South Africa through Expanded Access to Antiretroviral Therapy: A Model Comparison Study Jan A. C. Hontelez 1,2,3 *, Mark N. Lurie 4,5, Till Bärnighausen 3,6, Roel Bakker 1, Rob Baltussen

More information

Second generation HIV surveillance: Better data for decision making

Second generation HIV surveillance: Better data for decision making Second generation HIV surveillance: Better data for decision making Prof Thomas M Rehle, MD, PhD Human Sciences Research Council, South Africa HAI Conference on Prevention and Control of the HIV Epidemic

More information

Design of a Community Randomized HIV Prevention Trial in Botswana

Design of a Community Randomized HIV Prevention Trial in Botswana Design of a Community Randomized HIV Prevention Trial in Botswana Rui Wang, Ph.D. Department of Population Medicine Harvard Medical School and Harvard Pilgrim HealthCare Institute November 3rd, 2016 CRT:

More information

Optimal HIV testing strategies to achieve high levels of HIV diagnosis in South Africa

Optimal HIV testing strategies to achieve high levels of HIV diagnosis in South Africa Optimal HIV testing strategies to achieve high levels of HIV diagnosis in South Africa Leigh Johnson Centre for Infectious Disease Epidemiology and Research Background UNAIDS estimates that globally 70%

More information

Infectious Disease Epidemiology and Transmission Dynamics. M.bayaty

Infectious Disease Epidemiology and Transmission Dynamics. M.bayaty Infectious Disease Epidemiology and Transmission Dynamics M.bayaty Objectives 1) To understand the major differences between infectious and noninfectious disease epidemiology 2) To learn about the nature

More information

Modelling BCG vaccination in the UK: What is the impact of changing vaccination policy?

Modelling BCG vaccination in the UK: What is the impact of changing vaccination policy? Modelling BCG vaccination in the UK: What is the impact of changing vaccination policy? Sam Abbott Supervisors: Hannah Christensen, Ellen Brooks-Pollock University of Bristol 1 1. Lambert, M. L., Hasker,

More information

Potential Impact on HIV Incidence of Increasing Viral Suppression among HIV-positive MSM in Baltimore: Mathematical Modelling for HPTN 078

Potential Impact on HIV Incidence of Increasing Viral Suppression among HIV-positive MSM in Baltimore: Mathematical Modelling for HPTN 078 Potential Impact on HIV Incidence of Increasing Viral Suppression among HIV-positive MSM in Baltimore: Mathematical Modelling for HPTN 078 Kate M Mitchell, Brooke Hoots, Dobromir Dimitrov, Jason Farley,

More information

Downloaded from:

Downloaded from: Hayes, R; Fidler, S; Cori, A; Fraser, C; Floyd, S; Ayles, H; Beyers, N; El-Sadr, W; HPTN 071 (PopART) Study Team (2015) HIV Treatment-As-Prevention Research: Taking the Right Road at the Crossroads. PLoS

More information

Modelling the impact of HIV in South Africa s provinces: 2017 update

Modelling the impact of HIV in South Africa s provinces: 2017 update Modelling the impact of HIV in South Africa s provinces: 2017 update Centre for Infectious Disease Epidemiology and Research working paper September 2017 Leigh F. Johnson 1 Rob E. Dorrington 2 1. Centre

More information

Syllabus. Mathematical Modeling of Infectious diseases

Syllabus. Mathematical Modeling of Infectious diseases Syllabus Mathematical Modeling of Infectious diseases - 2009 Credit: 3 credits Faculty: Annelies Van Rie Teaching Assistant for computer practicum: Sarah Radke Time: Spring 2009, Monday, 1 3:50 PM Purpose

More information

Data inputs for HIV models and how they inform HIV prevention interventions Dobromir Dimitrov

Data inputs for HIV models and how they inform HIV prevention interventions Dobromir Dimitrov Data inputs for HIV models and how they inform HIV prevention interventions Dobromir Dimitrov Vaccine & Infectious Disease Division Fred Hutchinson Cancer Research Center Dynamic model integration The

More information

Technical Guidance Note for Global Fund HIV Proposals

Technical Guidance Note for Global Fund HIV Proposals Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United

More information

Understanding the Impact of an HIV Intervention Package for Adolescents

Understanding the Impact of an HIV Intervention Package for Adolescents Understanding the Impact of an HIV Intervention Package for Adolescents Faikah Bruce Supervisors: Dr. Leigh Johnson (UCT - CIDER) and Prof. Alex Welte (SU - SACEMA) 1 Contents Introduction Literature Review

More information

STI and HIV Prevention and Care among Sex Workers

STI and HIV Prevention and Care among Sex Workers Training Course in Sexual and Reproductive Health Research 2017 Module: Sexually transmitted infections, HIV/AIDS STI and HIV Prevention and Care among Sex Workers Annette Verster and Michelle Rodolph

More information

Q&A on HIV/AIDS estimates

Q&A on HIV/AIDS estimates Q&A on HIV/AIDS estimates 07 Last updated: November 2007 Understanding the latest estimates of the 2007 AIDS Epidemic Update Part one: The data 1. What data do UNAIDS and WHO base their HIV prevalence

More information

Combination prevention for HIV How to evaluate whether it works? Marie Laga Institute of Tropical Medicine Antwerp, Belgium

Combination prevention for HIV How to evaluate whether it works? Marie Laga Institute of Tropical Medicine Antwerp, Belgium Combination prevention for HIV How to evaluate whether it works? Marie Laga Institute of Tropical Medicine Antwerp, Belgium Preventing HIV includes Create an enabling environment Reduce Exposure behavior

More information

Mathematical Model Approach To HIV/AIDS Transmission From Mother To Child

Mathematical Model Approach To HIV/AIDS Transmission From Mother To Child Mathematical Model Approach To HIV/AIDS Transmission From Mother To Child Basavarajaiah.D. M. B. Narasimhamurthy, K. Maheshappa. B. Leelavathy ABSTRACT:- AIDS is a devastating disease, more than 2.50 million

More information

Information and Communication Technologies EPIWORK. Developing the Framework for an Epidemic Forecast Infrastructure.

Information and Communication Technologies EPIWORK. Developing the Framework for an Epidemic Forecast Infrastructure. Information and Communication Technologies EPIWORK Developing the Framework for an Epidemic Forecast Infrastructure http://www.epiwork.eu Project no. 231807 D1.1 Analysis of Epidemic Dynamics on Clustered

More information

Government of Canada Federal AIDS Initiative Milestones

Government of Canada Federal AIDS Initiative Milestones HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for

More information

HIV Treatment as Prevention: Considerations in the Design, Conduct, and Analysis of Cluster Randomized Controlled Trials of Combination HIV Prevention

HIV Treatment as Prevention: Considerations in the Design, Conduct, and Analysis of Cluster Randomized Controlled Trials of Combination HIV Prevention Review HIV Treatment as Prevention: Considerations in the Design, Conduct, and Analysis of Cluster Randomized Controlled Trials of Combination HIV Prevention Marie-Claude Boily 1 *, Benoît Mâsse 2, Ramzi

More information

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

Sex Work in Sub-Saharan Africa : Opportunities and Challenges Sex Work in Sub-Saharan Africa : Opportunities and Challenges Dr Traore Isidore May 26, 2016 Definition of Sex Worker Female, male and transgender adults (18 years of age and above) who receive money or

More information

ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS

ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS ACCELERATING HIV COMBINATION PREVENTION HIV COMBINATION PREVENTION INTERVENTIONS Dr T Chidarikire HIV PREVENTION STRATEGIES 13 JUNE 2017 1 Purpose To share the Health Sector HIV Prevention Strategy with

More information

HIV Modelling Consortium

HIV Modelling Consortium HIV Modelling Consortium Review of allocative efficiency tools Improving Efficiency in Health Conference Professor Timothy Hallett Ellen McRobie Aim & objectives of the HIV Modelling Consortium The HIV

More information

Modelling the spread of HIV/AIDS epidemic in the presence of irresponsible infectives

Modelling the spread of HIV/AIDS epidemic in the presence of irresponsible infectives African Journal of Biotechnology Vol. (5, pp. 87-95, 6 June, Available online at http://www.academicjournals.org/ajb DOI:.5897/AJB.786 ISSN 684-535 Academic Journals Full Length Research Paper Modelling

More information

Microbicides and HIV: Help or Hindrance? Eran Karmon, Malcolm Potts, and Wayne M. Getz

Microbicides and HIV: Help or Hindrance? Eran Karmon, Malcolm Potts, and Wayne M. Getz EPIDEMIOLOGY &SOCIAL SCIENCE Eran Karmon, Malcolm Potts, and Wayne M. Getz Abstract: We present a simple mathematical model for assessing the effects of introducing a microbicide as an HIV infection protective

More information

Male involvement in HIV Prevention Trials

Male involvement in HIV Prevention Trials Male involvement in HIV Prevention Trials Examples from HPTN071 Helen Ayles London School of Hygiene and Tropical Medicine Zambart, Lusaka, Zambia Introduction Equity is the absence of avoidable or remediable

More information

Mathematics for Infectious Diseases; Deterministic Models: A Key

Mathematics for Infectious Diseases; Deterministic Models: A Key Manindra Kumar Srivastava *1 and Purnima Srivastava 2 ABSTRACT The occurrence of infectious diseases was the principle reason for the demise of the ancient India. The main infectious diseases were smallpox,

More information

Stochastic Elements in Models to Support Disease Control Policy How Much Detail is Enough?

Stochastic Elements in Models to Support Disease Control Policy How Much Detail is Enough? Stochastic Elements in Models to Support Disease Control Policy How Much Detail is Enough? MARGARET BRANDEAU Department of Management Science & Engineering Department of Medicine Stanford University Agenda

More information

The Papua New Guinea HIV Model - Technical Appendix Technical Details and Calibration of the PNG HIV Model

The Papua New Guinea HIV Model - Technical Appendix Technical Details and Calibration of the PNG HIV Model The Papua New Guinea HIV Model - Technical Appendix Technical Details and Calibration of the PNG HIV Model Introduction This technical appendix provides a detailed description of the PNG HIV Model summarised

More information

Program to control HIV/AIDS

Program to control HIV/AIDS 90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,

More information

Downloaded from:

Downloaded from: Hallett, TB; Alsallaq, RA; Baeten, JM; Weiss, H; Celum, C; Gray, R; Abu-Raddad, L (2011) Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact

More information

WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections

WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections Common structure Universal Health Coverage SDGs Cascade of services Vision, Goals and Targets Costed Actions WHO Global Health Sector Strategies 2016-2021 HIV; Viral Hepatitis; Sexually Transmitted Infections

More information

Implementing interventions targeted at discordant couples: a feasibility analysis for 14 African countries

Implementing interventions targeted at discordant couples: a feasibility analysis for 14 African countries Implementing interventions targeted at discordant couples: a feasibility analysis for 14 African countries Brian J. Coburn and Sally Blower Center for Biomedical Modeling Semel Institute for Neuroscience

More information

Sexual health in adolescents in the UK: What do the data show? Dr Gwenda Hughes and Dr Anthony Nardone Health Protection Services Colindale

Sexual health in adolescents in the UK: What do the data show? Dr Gwenda Hughes and Dr Anthony Nardone Health Protection Services Colindale Sexual health in adolescents in the UK: What do the data show? Dr Gwenda Hughes and Dr Anthony Nardone Health Protection Services Colindale 30 November 2011 Overview Present data on sexual health in adolescents

More information

Modernization of North Carolina s HIV control measures

Modernization of North Carolina s HIV control measures Modernization of North Carolina s HIV control measures North Carolina Division of Public Health Victoria Mobley, MD MPH Evelyn Foust, MPH CPM Agenda Introduction Summary of scientific evidence used to

More information

Sexual Health reproduction in reference to treatment as/for prevention

Sexual Health reproduction in reference to treatment as/for prevention Sexual Health reproduction in reference to treatment as/for prevention The reasons for sexual reproductive health for PLHIV The number of people living with HIV (PLWH) continues to rise in the UK The increase

More information

2004 Update. Luxembourg

2004 Update. Luxembourg 2004 Update Luxembourg 2 Luxembourg HIV/AIDS estimates In 2003 and during the first quarter of 2004, UNAIDS and WHO worked closely with national governments and research institutions to recalculate current

More information

The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort

The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort Frank Tanser Presentation at the South African Clinicians Society Conference

More information

Supplemental Digital Content

Supplemental Digital Content Supplemental Digital Content 1 Methodology for estimating the contribution of identifiable HIV incidence among stable HIV-1 sero-discordant couples to total HIV population-level incidence We based our

More information

MODELLING THE SPREAD OF PNEUMONIA IN THE PHILIPPINES USING SUSCEPTIBLE-INFECTED-RECOVERED (SIR) MODEL WITH DEMOGRAPHIC CHANGES

MODELLING THE SPREAD OF PNEUMONIA IN THE PHILIPPINES USING SUSCEPTIBLE-INFECTED-RECOVERED (SIR) MODEL WITH DEMOGRAPHIC CHANGES MODELLING THE SPREAD OF PNEUMONIA IN THE PHILIPPINES USING SUSCEPTIBLE-INFECTED-RECOVERED (SIR) MODEL WITH DEMOGRAPHIC CHANGES Bill William M. Soliman 1, Aldous Cesar F. Bueno 2 1, 2 Philippine Science

More information

The role of dynamic modelling in drug abuse epidemiology

The role of dynamic modelling in drug abuse epidemiology Offprint from Bulletin on Narcotics, vol. LIV, Nos 1 and 2, 2002 The role of dynamic modelling in drug abuse epidemiology C. ROSSI Department of Mathematics, University of Rome Tor Vergata, Rome ABSTRACT

More information

B eyond individual benefits, the public health significance

B eyond individual benefits, the public health significance 24 ORIGINAL ARTICLE The potential epidemiological impact of a genital herpes vaccine for women G P Garnett, G Dubin, M Slaoui, T Darcis... See end of article for authors affiliations... Correspondence

More information

L4, Modeling using networks and other heterogeneities

L4, Modeling using networks and other heterogeneities L4, Modeling using networks and other heterogeneities July, 2017 Different heterogeneities In reality individuals behave differently both in terms of susceptibility and infectivity given that a contact

More information

REGIONAL PATTERN OF HIV CASES IN PAKISTAN ABSTRACT

REGIONAL PATTERN OF HIV CASES IN PAKISTAN ABSTRACT ORIGINAL ARTICLE REGIONAL PATTERN OF HIV CASES IN PAKISTAN 1,3 Department of Statistics, The Islamia University of Bahawalpur, 2 Director Campus Rahim Yar Khan & Department of Statistics, The Islamia University

More information

National Indicators for 2004

National Indicators for 2004 The Demographic Impact of HIV/AIDS in South Africa National Indicators for 2004 Prepared by Rob Dorrington, Debbie Bradshaw, Leigh Johnson and Debbie Budlender The Centre for Actuarial Research The Burden

More information

2006 Update. Brunei Darussalam

2006 Update. Brunei Darussalam 2006 Update Brunei Darussalam December 2006 HIV/AIDS estimates The estimates and data provided in the following tables relate to 2005 unless stated otherwise. These estimates have been produced and compiled

More information

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political

More information

T he epidemiology of infectious diseases has

T he epidemiology of infectious diseases has 7 RESEARCH METHODS An introduction to mathematical models in sexually transmitted disease epidemiology G P Garnett... Mathematical models serve a number of roles in understanding sexually transmitted infection

More information

Ending AIDS in Gabon: How long will it take? How much will it cost?

Ending AIDS in Gabon: How long will it take? How much will it cost? Ending AIDS in Gabon: How long will it take? How much will it cost? Brian G. Williams, Eleanor Gouws* and David Ginsburg South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch,

More information

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES JULY 2014 Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for

More information

Essentials of Aggregate System Dynamics Infectious Disease Models. Nathaniel Osgood CMPT 858 FEBRUARY 3, 2011

Essentials of Aggregate System Dynamics Infectious Disease Models. Nathaniel Osgood CMPT 858 FEBRUARY 3, 2011 Essentials of Aggregate System Dynamics Infectious Disease Models Nathaniel Osgood CMPT 858 FEBRUARY 3, 2011 Mathematical Models Link Together Diverse Factors Typical Factors Included Infection Mixing

More information

Community-Based TasP Trials: Updates and Projected Contributions. Reaching the target: Lessons from HPTN 071 (PopART) Sarah Fidler

Community-Based TasP Trials: Updates and Projected Contributions. Reaching the target: Lessons from HPTN 071 (PopART) Sarah Fidler Community-Based TasP Trials: Updates and Projected Contributions Reaching the 90-90-90 target: Lessons from HPTN 071 (PopART) Sarah Fidler Cascade of Care: Sub-Saharan Africa HIV test +ve in past 12 m

More information

The effect of infectiousness, duration of sickness, and chance of recovery on a population: a simulation study

The effect of infectiousness, duration of sickness, and chance of recovery on a population: a simulation study Research Article The effect of infectiousness, duration of sickness, and chance of recovery on a population: a simulation study McKayla Johnson, Tashauna Gilliam, and Istvan Karsai East Tennessee State

More information

Modelling and Simulation in Public Health

Modelling and Simulation in Public Health Modelling and Simulation in Public Health Margaret Brandeau Department of Management Science and Engineering Stanford University My talk today Need for analysis Four modeling/simulation studies Disease

More information

Modelling screening of HPV vaccinated birth cohorts. The infection transmission system

Modelling screening of HPV vaccinated birth cohorts. The infection transmission system Modelling screening of HPV vaccinated birth cohorts Dr. Iacopo Baussano Imperial College, London & UPO/CPO-Piemonte, Italy. The infection transmission system Infectious Agent in case of CC: men in case

More information

L2, Important properties of epidemics and endemic situations

L2, Important properties of epidemics and endemic situations L2, Important properties of epidemics and endemic situations July, 2016 The basic reproduction number Recall: R 0 = expected number individuals a typical infected person infects when everyone is susceptible

More information

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 1 Objectives of today s lecture Describe global goals in the fight against HIV Review the epidemiology

More information

HIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy

HIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy HIV in Russia Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy Elisa F. Long, M.S. Margaret L. Brandeau, Ph.D. Tatyana Vinichenko, M.D., M.P.A. Cristina M. Galvin, M.S. Swati

More information

Evaluating strategies for STI management in remote Indigenous communities of Australia

Evaluating strategies for STI management in remote Indigenous communities of Australia Evaluating strategies for STI management in remote Indigenous communities of Australia STIs in remote Indigenous communities Age group Gonorrhoea prevalence Chlamydia prevalence 16-19 13.5% 17.4% 20-24

More information

Concept paper on the guidance on the non-clinical and clinical development of medicinal products for HIV prevention including oral and topical PrEP

Concept paper on the guidance on the non-clinical and clinical development of medicinal products for HIV prevention including oral and topical PrEP 1 2 3 17 February 2011 EMA/86004/2011 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Concept paper on the guidance on the non-clinical and clinical development of medicinal products for

More information

Project : Long-term epidemiology of Meningococcal Meningitis in the African belt: dynamics and impact of vaccination

Project : Long-term epidemiology of Meningococcal Meningitis in the African belt: dynamics and impact of vaccination Project : Long-term epidemiology of Meningococcal Meningitis in the African belt: dynamics and impact of vaccination Spatio-temporal dynamics (spread, persistence, periodicity), Comparative approach, impact

More information

HIV Prevention Prioritization & Implementation Brief: Benue State

HIV Prevention Prioritization & Implementation Brief: Benue State HIV Prevention Prioritization & Implementation Brief: Benue State Introduction The HIV epidemic in Nigeria is complex, with substantial heterogeneity in HIV prevalence across different regions and diverse

More information

SPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV

SPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV SPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV PREVENTION COALITION MEETING, 10 OCTOBER2017 I have said many times, and wish to repeat, that

More information

Supplementary Methods. HIV Synthesis Transmission V1. Model details

Supplementary Methods. HIV Synthesis Transmission V1. Model details Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second line antiretroviral regimens in resource-limited settings. Supplementary

More information

Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence

Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine Viral suppression

More information

Circular Migrations and HIV Transmission Dynamics

Circular Migrations and HIV Transmission Dynamics Circular Migrations and HIV Transmission Dynamics Aditya Khanna A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science University of Washington 2009 Program Authorized

More information

Torin Schaafsma. A thesis submitted in partial fulfillment of the requirements for the degree of. Master of Science. University of Washington 2015

Torin Schaafsma. A thesis submitted in partial fulfillment of the requirements for the degree of. Master of Science. University of Washington 2015 Estimating the impact of identifying and treating HIV-infected male circumcision clients in Uganda, Zambia, and Swaziland: a mathematical modeling analysis Torin Schaafsma A thesis submitted in partial

More information

Levels and Predictors of Condom Use in Extramarital Sex among Women in Four sub- Saharan African Countries

Levels and Predictors of Condom Use in Extramarital Sex among Women in Four sub- Saharan African Countries Levels and Predictors of Condom Use in Extramarital Sex among Women in Four sub- Saharan African Countries Onipede Wusu, PhD Department of Sociology, Lagos State University, Lagos, Nigeria onipedewusu@yahoo.com;

More information

Modelling HIV Transmission and Treatment for US MSM to Estimate the Impact of HPTN 078 on HIV Incidence

Modelling HIV Transmission and Treatment for US MSM to Estimate the Impact of HPTN 078 on HIV Incidence Modelling HIV Transmission and Treatment for US MSM to Estimate the Impact of HPTN 078 on HIV Incidence Kate Mitchell, PhD Imperial College London London, UK 14 th June 2016 Introduction: HPTN 078 Enhancing

More information

On Simulation of the Effect of Compatibility Test on the Transmission Dynamics of HIV in a Heterosexual Population

On Simulation of the Effect of Compatibility Test on the Transmission Dynamics of HIV in a Heterosexual Population On Simulation of the Effect of Compatibility Test on the Transmission Dynamics of HIV in a Heterosexual Population Onoja Abu 1 Patrick Noah Okolo 2* 1. Department of Mathematics and Statistics, Federal

More information

PrEP May Cause a Revolution in HIV Prevention: Time to Get Ready

PrEP May Cause a Revolution in HIV Prevention: Time to Get Ready PrEP May Cause a Revolution in HIV Prevention: Time to Get Ready Thomas J. Coates PhD Michael and Sue Steinberg Professor of Global AIDS Research David Geffen School of Medicine University of California,

More information

PREDICTABILITY OF PREVALENCE OF SEXUALLY TRANSMITTED INFECTION ON COMPLEX NETWORK

PREDICTABILITY OF PREVALENCE OF SEXUALLY TRANSMITTED INFECTION ON COMPLEX NETWORK Tuesday, July 24th, 10:30 PREDICTABILITY OF PREVALENCE OF SEXUALLY TRANSMITTED INFECTION ON COMPLEX NETWORK Ryosuke Omori omori@czc.hokudai.ac.jp Research Center for Zoonosis Control, Hokkaido University,

More information

STI control. Dr. Jane Morgan Hamilton Sexual Health Clinic

STI control. Dr. Jane Morgan Hamilton Sexual Health Clinic STI control Dr. Jane Morgan Hamilton Sexual Health Clinic Overview STI control in theory NZ s reality Where to from here? STI control framework R0=ßcD R0 = reproductive rate; the rate at which infection

More information

Steady Ready Go! teady Ready Go. Every day, young people aged years become infected with. Preventing HIV/AIDS in young people

Steady Ready Go! teady Ready Go. Every day, young people aged years become infected with. Preventing HIV/AIDS in young people teady Ready Go y Ready Preventing HIV/AIDS in young people Go Steady Ready Go! Evidence from developing countries on what works A summary of the WHO Technical Report Series No 938 Every day, 5 000 young

More information

HIV/AIDS: Trends, Forecasts, Exploring HIV Policy and Program Alternative Predictions Using Deterministic Asian Epidemic Model

HIV/AIDS: Trends, Forecasts, Exploring HIV Policy and Program Alternative Predictions Using Deterministic Asian Epidemic Model HIV/AIDS: Trends, Forecasts, Exploring HIV Policy and Program Alternative Predictions Using Deterministic Asian Epidemic Model Damodar Sahu, National Institute of Medical Statistics (ICMR), India Niranjan

More information

Sexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012

Sexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012 Sexual and Reproductive Health and HIV Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012 Global estimates of HIV-(2009) People living with HIV 33.3 million [31.4 35.3

More information

A Model for the CD4 Cell Counts in an HIV/AIDS Patient and its Application in Treatment Interventions

A Model for the CD4 Cell Counts in an HIV/AIDS Patient and its Application in Treatment Interventions American Journal of Infectious Diseases (): 6-65, 5 ISSN: 553-63 5 Science Publications A Model for the CD4 Cell Counts in an HIV/AIDS Patient and its Application in Treatment Interventions Richard O.

More information

Global and National trends of HIV/AIDS

Global and National trends of HIV/AIDS Research and Review Insights Research Article ISSN: 2515-2637 Global and National trends of HIV/AIDS Hikmat Bahadur Raya* Lecturer, Department of Population Studies, Tribhuvan University, Terhathum M.

More information

World Health Organization. A Sustainable Health Sector

World Health Organization. A Sustainable Health Sector World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL

More information

Module 5: Introduction to Stochastic Epidemic Models with Inference

Module 5: Introduction to Stochastic Epidemic Models with Inference Module 5: Introduction to Stochastic Epidemic Models with Inference Instructors:, Dept. Mathematics, Stockholm University Ira Longini, Dept. Biostatistics, University of Florida Jonathan Sugimoto, Vaccine

More information

MODELLING INFECTIOUS DISEASES. Lorenzo Argante GSK Vaccines, Siena

MODELLING INFECTIOUS DISEASES. Lorenzo Argante GSK Vaccines, Siena MODELLING INFECTIOUS DISEASES Lorenzo Argante GSK Vaccines, Siena lorenzo.x.argante@gmail.com GSK IN A NUTSHELL GSK VACCINES - GLOBAL PRESENCE SIENA RESEARCH AND DEVELOPMENT (R&D) SITE EXPLORATORY DATA

More information

HHS Public Access Author manuscript J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2017 August 01.

HHS Public Access Author manuscript J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2017 August 01. PrEP adherence patterns strongly impact individual HIV risk and observed efficacy in randomized clinical trials Dobromir T. DIMITROV, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research

More information

Why Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV?

Why Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV? Why Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV? Epidemiology of HIV in Adolescent & Young Women Lynne M. Mofenson MD Elizabeth Glaser Pediatric AIDS Foundation

More information

Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study

Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study Narat Punyacharoensin, William John Edmunds, Daniela De Angelis,

More information

The mathematics of diseases

The mathematics of diseases 1997 2004, Millennium Mathematics Project, University of Cambridge. Permission is granted to print and copy this page on paper for non commercial use. For other uses, including electronic redistribution,

More information

2004 Update. Georgia

2004 Update. Georgia 24 Update Georgia 2 Georgia HIV/AIDS estimates In 23 and during the first quarter of 24, UNAIDS and WHO worked closely with national governments and research institutions to recalculate current estimates

More information

QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE

QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE CONTACT: Lisa Rossi +1-412-641-8940 +1-412- 916-3315 (mobile) rossil@upmc.edu QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE 1. What is the Partners PrEP study? The Partners PrEP Study is a double-blind,

More information

2004 Update. Seychelles

2004 Update. Seychelles 2004 Update Seychelles 2 Seychelles HIV/AIDS estimates In 2003 and during the first quarter of 2004, UNAIDS and WHO worked closely with national governments and research institutions to recalculate current

More information

Module 5: Introduction to Stochastic Epidemic Models with Inference

Module 5: Introduction to Stochastic Epidemic Models with Inference Module 5: Introduction to Stochastic Epidemic Models with Inference Instructors: Tom Britton, Dept. Mathematics, Stockholm University Ira Longini, Dept. Biostatistics, University of Florida Jonathan Sugimoto,

More information

DOWNLOAD OR READ : NATIONAL HIV AIDS STRATEGY PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : NATIONAL HIV AIDS STRATEGY PDF EBOOK EPUB MOBI DOWNLOAD OR READ : NATIONAL HIV AIDS STRATEGY PDF EBOOK EPUB MOBI Page 1 Page 2 national hiv aids strategy national hiv aids strategy pdf national hiv aids strategy EXECUTIVE SUMMARY 1 EXECUTIVE SUMMARY

More information

REGULATORY PATHWAYS AND CLINICAL TRIAL DESIGN FOR LONG-ACTING PrEP

REGULATORY PATHWAYS AND CLINICAL TRIAL DESIGN FOR LONG-ACTING PrEP REGULATORY PATHWAYS AND CLINICAL TRIAL DESIGN FOR LONG-ACTING PrEP PERSPECTIVES FROM A THEMATIC ROUNDTABLE ORGANIZED BY THE IAS INDUSTRY LIAISON FORUM BACKGROUND Since the first Phase III trials eight

More information

The roadmap. Why do we need mathematical models in infectious diseases. Impact of vaccination: direct and indirect effects

The roadmap. Why do we need mathematical models in infectious diseases. Impact of vaccination: direct and indirect effects Mathematical Models in Infectious Diseases Epidemiology and Semi-Algebraic Methods Why do we need mathematical models in infectious diseases Why do we need mathematical models in infectious diseases Why

More information

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness

More information

South African Guidelines for the Safe Use of. Dr. Oscar Radebe

South African Guidelines for the Safe Use of. Dr. Oscar Radebe South African Guidelines for the Safe Use of PrEP in MSM Dr. Oscar Radebe Background Globally MSM(men who have sex with men) have been disproportionately at high risk of HIV transmission. Biological &

More information

Since the start t of the HIV/ 1980 s: 77.3 million people have be. In million people were liv

Since the start t of the HIV/ 1980 s: 77.3 million people have be. In million people were liv The HIV/AIDS Epidemic and Sustainable Development tgoals Etienne Karita, MD MSc MSPH Kigali, 8 Nov 018 IV/AIDS Burden Since the start t of the HIV/ V/AIDS epidemic i in the early 1980 s: 77.3 million people

More information